M
M Wilson
Researcher at University of Oxford
Publications - 8
Citations - 2899
M Wilson is an academic researcher from University of Oxford. The author has contributed to research in topics: Aspirin & Cancer. The author has an hindex of 5, co-authored 8 publications receiving 2649 citations.
Papers
More filters
Journal ArticleDOI
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.
Peter M. Rothwell,M Wilson,Carl-Eric Elwin,Bo Norrving,Ale Algra,Charles P Warlow,Tom W. Meade +6 more
TL;DR: Benefit was greatest for cancers of the proximal colon, which are not otherwise prevented effectively by screening with sigmoidoscopy or colonoscopy, and benefit increased with scheduled duration of treatment.
Journal ArticleDOI
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
TL;DR: It is suggested that aspirin might help in treatment of some cancers and provides proof of principle for pharmacological intervention specifically to prevent distant metastasis in patients who developed cancer during trials of daily aspirin versus control.
Journal ArticleDOI
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
Peter M. Rothwell,Jacqueline F. Price,F. Gerald R. Fowkes,Alberto Zanchetti,Maria Carla Roncaglioni,Gianni Tognoni,Robert J. Lee,Jill F. F. Belch,M Wilson,Ziyah Mehta,Tom W. Meade +10 more
TL;DR: The short-term reductions in cancer incidence and mortality and the decrease in risk of major extracranial bleeds with extended use, and their low case-fatality, add to the case for daily aspirin in prevention of cancer.
Journal ArticleDOI
Blind outcome assessment: the development and use of procedures to maintain and describe blinding in a pragmatic physiotherapy rehabilitation trial
TL;DR: Specific trial protocols enabled blinding beliefs to be reported and instances of unblinding to be described and blind outcome assessment was considered achievable in this trial.
Journal ArticleDOI
Response of Day-to-Day Home Blood Pressure Variability by Antihypertensive Drug Class After Transient Ischemic Attack or Nondisabling Stroke
TL;DR: Day-to-day variability on home BP readings predicts stroke risk and potentially offers a practical method of monitoring response to variability-directed treatment in patients with recent cerebrovascular events.